The pandemic of coronavirus 19 (COVID-19) infection has presented the clinicians with a challenge never experienced on this scale before. Although coagulopathy has been well described in association with COVID-19 infection, some recommendations have emerged so far for the potential role of empiric anticoagulation in specific situations. We describe a case of a middle-aged male with extensive acute lower limb ischemia and severe pneumonia related to COVID-19 infection. This case highlights the role of prophylactic anticoagulation in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection regardless of co-morbidities and D- dimer levels.
All Keywords
【저자키워드】 anticoagulation, diabetes, Coagulopathy, COVID-19 infection, limb ischemia, 【초록키워드】 COVID-19, SARS-CoV-2, coronavirus, pandemic, Infection, Prophylactic, male, co-morbidity, severe pneumonia, association, Ischemia, lower limb, acute respiratory syndrome, clinician, recommendation, highlight, described, D- dimer, with COVID-19, 【제목키워드】 COVID-19,
【저자키워드】 anticoagulation, diabetes, Coagulopathy, COVID-19 infection, limb ischemia, 【초록키워드】 COVID-19, SARS-CoV-2, coronavirus, pandemic, Infection, Prophylactic, male, co-morbidity, severe pneumonia, association, Ischemia, lower limb, acute respiratory syndrome, clinician, recommendation, highlight, described, D- dimer, with COVID-19, 【제목키워드】 COVID-19,